I am a mathematical biologist and a bioinformatics researcher in the pharmaceutical industry. I received my Ph.D. in Life Science from Hokkaido University in March 2025.
I study biological dynamics using mathematical models and data analysis, with an interest in pharmacometrics and systems biology.
ORCIDGoogle ScholarLinkedInGitHub
A known-motif audit of two public phage genomes separates sequence-pattern verification from autonomous discovery. Reported campaign counts, identifier-limited zero recoveries in ten reruns and fixed-input recognition are kept distinct from molecular function.
A one-marker, known-condition diagnostic on public 4i data compares mean-based predictions and a quantile map. Distributional agreement is separated from lineage identification, biological replication and resistance. No CellOT or CMonge model was trained.
A source-typed audit of revumenib and ziftomenib separates calibration, prediction and clinical evidence. Reduced-model calculations examine joint endpoint tolerances, cross-drug borrowing and mechanistic ambiguity without claiming independent clinical validation.